ASND Q1 2026 Earnings EPS Misses Estimates as Ascendis Pharma Navigates Cost Pressures BLFY Q3 2025 Earnings EPS Falls Short of Estimates Amid Challenging Operating Environment NNOX Q4 2025 Earnings WiderThanExpected Loss as Revenue Details Remain Scarce Guardian Pharmacy Services GRDN Q1 2026 Earnings EPS Misses Estimates Despite Positive Stock Movement Immunocore IMCR Q1 2026 Earnings Stunning EPS Beat Masks Caution as Shares Slide 39 XOMA Royalty Corporation Q1 2026 Earnings EPS Misses Estimates Royalty Revenues Under Scrutiny